Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1
Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.
Related Posts
Fang D, McWIlliams J, Wang C, Maziero D, Iwamoto KS, Kishan AU, Finn JP, Zhong X, Ruan D. In-Depth optimization and characterization of prostatic and[...]
Zhang Y, Siu KL, Huang K, Huang Y, Cai H. Attenuation of advanced atherosclerosis and aortic aneurysm in hph-1/apoE DKO mice by folic acid and[...]
Miyazaki K, Olivas JA, Miyazaki Y, Sato T, Rimmer M, Moussa ID, Fishbein MC, Shivkumar K, Mori S. Impinged and Disrupted Left Bundle Branch by[...]